Drug-Using Women Need Comprehensive Sexual Risk Reduction Interventions

Clinical Infectious Diseases

Volumn 37, Issue 12 SUPPL. 5, 2003, Pages

  Latka, Mary ^a  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; COMMUNITY CARE; CONDOM; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE NEED; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFECTION RISK; PRIORITY JOURNAL; RISK; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; UNITED STATES;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; WOMEN'S HEALTH SERVICES;

EID: 0347479188     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377566     Document Type: Article

References (77)

1. Hahn RA, Onorato IM, Jones S, Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989; 261:2677-85.
2. Centers for Disease Control and Prevention. Update: acquired immunodeficiency syndrome - United States, 1992. MMWR Morb Mortal Wkly Rep 1993; 42:547-51.
3. National Center for HIV, STD, and TB Prevention. Table 24: estimated adult/adolescent AIDS incidence by sex, exposure category and year of diagnosis, 1996-2000, United States. HIV AIDS Surveill Rep 2002; 13. Available at: http://www.cdc.gov/hiv/stats/hastr1301/table24.htm. Accessed 22 March 2002.
4. Battjes RJ, Pickens RW, Brown LS. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:90-6.
5. Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92:385-7.
6. Semaan, S, Kotranski L, Collier K, Lauby J, Halbert J, Feighan K. Temporal trends in HIV risk behaviors of out-of-treatment injection drug users and injection drug users who smoke crack. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:274-81.
7. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:282-9.
8. Latka M, Ahern J, Garfein R, et al. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse 2001; 13:73-88.
9. Maslow CB, Friedman SR, Perlis TE, Rockwell R, Des Jarlais DC. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health 2002; 92:382-4.
10. Cottler LB, Leukefeld C, Hoffman J, et al. Effectiveness of HIV risk reduction initiatives among out-of-treatment non-injection drug users. J Psychoactive Drugs 1998; 30:279-90.
11. McMahon RC, Malow RM, Jennings TE, Gomez CJ. Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Educ Prev 2001; 13:91-107.
12. Warner BD, Leukefeld CG. Assessing the differential impact of an HIV prevention intervention: who's putting the message into practice? AIDS Educ Prev 2001; 13:479-94.
13. Prendergast ML, Urada D, Podus DJ. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol 2001; 69:389-405.
14. Brook DW, Brook JS, Richter L, Masci JR, Roberto J. Needle sharing: a longitudinal study of female injection drug users. Am J Drug Alcohol Abuse 2000; 26:263-81.
15. Kotranski L, Semaan S, Collier K, Lauby J, Halber J, Feighan K. Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users. AIDS Educ Prev 1998; 10:19-33.
16. Coyle SL, Needle RH, Normand J. Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep 1998; 113(Suppl 1):19-30.
17. Dinwiddie SH. Characteristics of injection drug users derived from a large family study of alcoholism. Compr Psychiatry 1997; 38:218-29.
18. Kim MY, Marmor M, Dubin N, Wolfe H. HIV risk-related sexual behaviors among heterosexuals in New York City: associations with race, sex, and intravenous drug use. AIDS 1993; 7:409-14.
19. Buchacz K, van der Straten A, Saul J, Shiboski SC, Gomez CA, Padian N. Sociodemographic, behavioral, and clinical correlates of inconsistent condom use in HIV-serodiscordant heterosexual couples. J Acquir Immune Defic Syndr 2001; 28:289-97.
20. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989; 321:874-9.
21. Doherty MC, Garfein RS, Monterroso E, et al. Correlates of HIV injection among young adult short-term injection drug users. AIDS 2000; 14:1-10.
22. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001; 357:1397-401.
23. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001; 161:1281-8.
24. Solomon L, Astemborski J, Warren D, et al. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol 1993; 137:892-8.
25. National Center for HIV, STD, and TB Prevention, Division of HIV/ AIDS Prevention. HIV/AIDS among US women: minority and young women at continuing risk. March, 2002. Available at: http://www.cdc. gov/hiv/pubs/facts/women.htm. Accessed 22 March 2002.
26. Neal JJ, Fleming PL, Green TA, Ward JW. Trends in heterosexually acquired AIDS in the United States, 1988 through 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:465-74.
27. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the Millennium. JAMA 2001; 285:1186-92.
28. New York City Department of Health HIV Epidemiology Group. 25 years of HIV in New York City: lessons from surveillance. J Urban Health 2001; 78:669-78.
29. Weinstock H, Dale M, Gwinn M, et al. HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr 2002; 29:478-83.
30. Vlahov D, Brewer TF, Castro KG, et al. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265:1129-32.
31. Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002; 166:894-9.
32. Fordyce EJ, Blum S, Shum R, Singh TP, Chiasson MA, Thomas P. The changing AIDS epidemic in New York City: a descriptive birth cohort analysis of AIDS incidence and age at diagnosis. AIDS 1995; 9:605-10.
33. Lee LM, Fleming PL. Trends in human immunodeficiency virus diagnoses among women in the United States, 1994-1998. J Am Med Womens Assoc 2001; 56:94-9.
34. National Center for HIV, STD, and TB Prevention. Table 6: HIV infection cases by age group, exposure category, and sex, reported through June 2001, from the 36 areas with confidential HIV infection reporting. HIV AIDS Surveill Rep 2002; 13. Available at: http://www. cdc.gov/hiv/stats/hasr1301/table6.htm. Accessed 22 March 2002.
35. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994; 84:382-7.
36. Latkin CA, Mandell W, Knowlton AR, et al. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev 1998; 10:257-63.
37. Flom PL, Friedman SR, Kottiri BJ, et al. Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood. Sex Transm Dis 2001; 28:598-607.
38. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991; 266:1664-7.
39. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-7.
40. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-9.
41. Macaluso M, Demand MJ, Artz LM, Hook EW 3rd. Partner type and condom use. AIDS 2000; 14:537-46.
42. Cooper ML, Orcutt HK. Alcohol use, condom use and partner type among heterosexual adolescents and young adults. J Stud Alcohol 2000; 61:413-9.
43. Ku L, Sonenstein FL, Pleck JH. The dynamics of young men's condom use during and across relationships. Fam Plann Perspect 1994; 26:246-51.
44. Bankole A, Darroch JE, Singh S. Determinants of trends in condom use in the United States, 1988-1995. Fam Plann Perspect 1999; 31:264-71.
45. Soler H, Quadagno D, Sly DF, Riehman KS, Eberstein IW, Harrison DF. Relationship dynamics, ethnicity and condom use among low-income women. Fam Plann Perspect 2000; 32:82-8, 101.
46. Wingood GM, DiClemente RJ. Partner influences and gender-related factors associated with non-condom use among young adult African American women. Am J Community Psychol 1998; 26:29-51.
47. Hser YI, Anglin MD, McGlothlin W. Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse 1987; 13:33-57.
48. Diaz T, Vlahov, Edwards V, et al. Sex-specific differences in circumstances of initiation into injecting-drug use among young adult Latinos in Harlem, New York City. AIDS Behav 2002; 6:117-22.
49. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health 2000; 77:396-414.
50. Greenberg JB. Childhood sexual abuse and sexually transmitted diseases in adults: a review of, and implications for, STD/HIV programmes. Int J STD AIDS 2001; 12:777-83.
51. Kline A, VanLandingham M. HIV-infected women and sexual risk reduction: the relevance of existing models of behavior change. AIDS Educ Prev 1994; 6:390-402.
52. Cohen D, Spear S, Scribner R, Kissinger P, Mason K, Wildgen J. "Broken windows" and the risk of gonorrhea. Am J Public Health 2000; 90:230-6.
53. Crosby RA, DiClemente RJ, Wingood GM, Harrington K, Davies S, Malow R. Participation by African-American adolescent females in social organizations: associations with HIV-protective behaviors. Ethn Dis 2002; 12:186-92.
54. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for IV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol 1994; 22:415-30.
55. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:273-80.
56. World Health Organization (WHO).The female condom: a review. Geneva: WHO, 1997.
57. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 2001; 15:1595-602.
58. Uckun FM, D'Cruz OJ. Prophylactic contraceptives for HIV/AIDS. Hum Reprod Update 1999; 5:506-14.
59. Latka M. Female-initiated methods for the prevention of STI/HIV: where are we now? Where should we go? J Urban Health 2001; 78: 571-82.
60. Booth RE, Watters JK. How effective are risk-reduction interventions targeting injecting drug users? AIDS 1994; 8:1515-24.
61. Helweg-Larsen M, Collins BE. A social psychological perspective on the role of knowledge about AIDS in AIDS prevention. Curr Dir Psychol Sci 1997; 6:23-53.
62. Fisher JD, Fisher WA. Theoretical approaches to individual level change in HIV risk behavior. In: Peterson JL, DiClemente RJ, eds. Handbook of HIV prevention. New York: Kluwer Academic/Plenum Publishers, 2000:3-49.
63. Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS 1998; 12:919-29.
64. Jemmott JB 3rd, Jemmott LS. HIV risk reduction behavioral interventions with heterosexual adolescents. AIDS 2000; 14(Suppl 2): S40-52.
65. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280:1161-7.
66. Kwiatkowski CF, Stober DR, Booth RE, Zhang Y. Predictors of increased condom use following HIV intervention with heterosexually active drug users. Drug Alcohol Depend 1999; 54:57-62.
67. Des Jarlais DC, Abdul-Quader A, Tross S. The next problem: maintenance of AIDS risk reduction among intravenous drug users. Int J Addict 1991; 26:1279-92.
68. Myers DG. Social psychology. New York: McGraw-Hill, 1987.
69. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano D. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol 1996; 24:341-64.
70. Sormanti M, Pereira L, El-Bassel N, Witte S, Gilbert L. The role of community consultants in designing an HIV prevention intervention. AIDS Educ Prev 2001; 13:311-28.
71. Penman-Aguilar A, Hall J, Artz L, et al. Presenting the female condom to men: a dyadic analysis of effect of the woman's approach. Women Health 2002; 35:37-51.
72. Van Devanter N, Gonzales V, Merzel C, Parikh NS, Celantano D, Greenberg J. Effect of an STD/HIV behavioral intervention on women's use of the female condom. Am J Public Health 2002; 92:109-15.
73. Piotrow PT, Kincaid DL, Hindin MJ, et al. Changing men's attitudes and behavior: the Zimbabwe Male Motivation Project. Stud Fam Plann 1992; 23:365-75.
74. Balaiah D, Naik DD, Parida RC, Ghule M, Hazari KT, Juneja HS. Contraceptive knowledge, attitude, and practices of men in rural Maharashtra. Adv Contracept 1999; 15:217-34.
75. Wang CC, Vittinghoff E, Hua LS, Yun WH, Rong ZM. Reducing pregnancy and induced abortion rates in China: family planning with husband participation. Am J Public Health 1998; 88:646-8.
76. Sikkema KJ, Kelly JA, Winett RA, et al. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. Am J Public Health 2000; 90: 57-63.
77. Cohen DA, Farley TA, Bedimo-Etame JR, et al. Implementation of condom social marketing in Louisiana, 1993 to 1996. Am J Public Health 1999; 89:204-8.